Latest News - Transfection Technologies Market: Viral-vector is expected to lead the Type segment during 2025-2029

The Transfection Technologies Market is being driven by Rising demand for monoclonal antibodies

The Transfection Technologies Market is expected to grow at a CAGR of 9.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 746.2 million. In the realm of biotechnology and pharmaceutical research, the adoption of dual-reporter systems has surged due to their distinct advantages over single-reporter systems. These systems enable normalization of expression for both cell number and transfection efficiency, mitigating potential issues arising from variable growth conditions that can significantly impact gene expression in single-reporter systems. With the Nano-Glo Dual-Luciferase Reporter (NanoDLR) Assay System from Promega Corp, researchers can simultaneously detect the activities of firefly luciferase and NanoLuc luciferase within a single sample, thereby facilitating accurate determination of treatment effects versus experimental reporter responses. 

Get more information on Transfection Technologies Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Viral-vector
  • Physical transfection
  • Biochemical based transfection
• End-user
  • Pharmaceutical and biotechnology companies
  • Contract research organizations
  • Academic and research institutes
• Product Type
  • Kits and reagents
  • Equipment
  • Others
• Application
  • Biomedical Research
  • Therapeutic Delivery
  • Protein Production
  • Gene Editing
  • Cell Line Development
• Geography
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • UK
  • Asia
  • Rest of World (ROW)
    • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising demand for monoclonal antibodies
• Continued developments in transfection technologies by market companies
• Growing adoption of CRISPR/Cas9 gene editing technology

However, the market also witnesses some limitations, which are as follows:

• Issues associated with efficiency of transfection
• Limited sustainability of small companies
• Lack of promotional activities

Benefits of Buying Global Transfection Technologies Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Transfection Technologies Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Transfection Technologies Market encompasses various methods for introducing foreign genetic material into cells, including liposomal formulations, synthetic vectors, and viral vectors such as lentiviral and adenoviral. Technological advancements include transfection optimization software, cell line engineering, high-throughput screening, gene expression analysis, transfection monitoring, in vivo imaging, and more. Applications span therapeutic, diagnostic, and personalized medicine, with a focus on transfection efficacy, reproducibility, consistency, safety, clinical trial design, endpoints, validation, standardization, quality control, scale-up, manufacturing, commercialization, and market trends. Innovation continues to drive improvements in transfection technologies.

Market Research Overview

The global life sciences tools and services market encompasses businesses involved in the research and development (R&D) of various product categories, including capital equipment, instruments, accessories, and consumables for pharmaceuticals, biotechnology, and laboratory diagnosis. Additionally, this market covers life sciences-related services, such as contract research, manufacturing, and sales. According to Technavio, the healthcare market size is determined by the combined revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. The expansion of the global life science tools and services market is attributable to several factors, including the increasing aging population, leading to a rise in demand for healthcare solutions, and the growing emphasis on gene delivery techniques, such as non-viral transfection using transfection reagents like lipid nanoparticles, and viral transfection, to advance research and development in the pharmaceutical and biotechnology industries. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/